Implantable cell pouches as living medicines to treat chronic diseases
MedCity News - 09-Aug-2021Encellin's encapsulation device protects implanted cells, promising targeted cell therapy
Crystal Nyitray
CEO and Co-founder of Encellin
CEO and Co-founder of Encellin. Crystal Nyitray authored more than 10 patents.
She holds a PhD in Chemistry and Chemical Biology from University of California, San Francisco. She completed her Bachelor's in Biochemistry and Molecular Biology from University of California, Santa Cruz.
Visit website: https://www.encellin.com/about#CrustalNyitray
See also: 
Encellin
- Cell-based therapeutics to help patients with chronic unmet clinical needs
Details last updated 11-Aug-2021
Crystal Nyitray News
